COAPTITE

Agent, Bulking, Injectable For Gastro-urology Use

FDA Premarket Approval P040047

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for coaptite. The device is indicated for soft tissue augmentation in the treatment of stress urinary incontinence (sui) due to intrinsic sphincter deficiency (isd) in adult females.

DeviceCOAPTITE
Classification NameAgent, Bulking, Injectable For Gastro-urology Use
Generic NameAgent, Bulking, Injectable For Gastro-urology Use
ApplicantMERZ NORTH AMERICA, INC
Date Received2004-12-09
Decision Date2005-11-10
Notice Date2005-11-28
PMAP040047
SupplementS
Product CodeLNM
Docket Number05M-0477
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address MERZ NORTH AMERICA, INC 4133 Courtney Road suite 10 franksville, WI 53126
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040047Original Filing
S069 2022-12-15 30-day Notice
S068 2022-12-09 30-day Notice
S067 2022-11-01 30-day Notice
S066 2022-11-01 30-day Notice
S065
S064
S063 2020-09-25 30-day Notice
S062 2020-09-18 30-day Notice
S061 2020-09-18 30-day Notice
S060
S059
S058 2020-04-21 30-day Notice
S057 2020-04-03 30-day Notice
S056
S055 2019-05-16 135 Review Track For 30-day Notice
S054 2019-05-10 30-day Notice
S053 2019-05-09 30-day Notice
S052 2019-01-07 Normal 180 Day Track No User Fee
S051 2018-04-30 30-day Notice
S050
S049 2018-01-16 30-day Notice
S048
S047 2017-10-19 30-day Notice
S046 2017-10-12 Normal 180 Day Track No User Fee
S045 2017-06-01 30-day Notice
S044 2016-12-06 135 Review Track For 30-day Notice
S043 2016-05-31 30-day Notice
S042 2015-09-04 30-day Notice
S041 2015-06-26 30-day Notice
S040 2015-05-01 135 Review Track For 30-day Notice
S039 2015-04-02 30-day Notice
S038 2015-03-27 135 Review Track For 30-day Notice
S037 2014-10-06 30-day Notice
S036 2014-06-17 30-day Notice
S035 2014-05-23 30-day Notice
S034 2014-02-25 30-day Notice
S033 2014-01-09 30-day Notice
S032 2013-11-25 30-day Notice
S031 2013-11-20 30-day Notice
S030 2013-10-31 30-day Notice
S029 2013-09-27 30-day Notice
S028 2013-09-25 30-day Notice
S027 2013-06-21 30-day Notice
S026 2013-05-08 30-day Notice
S025 2013-02-04 30-day Notice
S024 2012-09-20 30-day Notice
S023
S022
S021 2011-07-25 135 Review Track For 30-day Notice
S020 2011-06-08 30-day Notice
S019 2011-01-12 Normal 180 Day Track No User Fee
S018 2011-01-11 Normal 180 Day Track No User Fee
S017 2010-05-17 30-day Notice
S016 2010-02-12 30-day Notice
S015 2009-10-06 30-day Notice
S014 2009-02-06 30-day Notice
S013 2009-02-05 135 Review Track For 30-day Notice
S012 2008-12-08 30-day Notice
S011 2008-11-06 135 Review Track For 30-day Notice
S010 2008-10-21 135 Review Track For 30-day Notice
S009 2008-10-16 30-day Notice
S008 2008-08-04 30-day Notice
S007 2008-06-30 30-day Notice
S006 2008-06-30 30-day Notice
S005
S004 2007-11-20 135 Review Track For 30-day Notice
S003 2007-05-24 30-day Notice
S002 2007-04-18 30-day Notice
S001 2005-12-09 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
08714729804796 P040047 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.